PROM1 and acute myeloid leukemia: In AML samples EVs expressing CD29, CD44, or SSEA-4 were found to be consistently increased compared to HBD, in subgroups of AML patients CD133 (6/17), CD105 (7/17), CD146 (4/17) were also found to be increased.